 | |
| Names | |
|---|---|
| Preferred IUPAC name 3-{2-[Methyl(propyl)amino]ethyl}-1H-indol-4-ol | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider |
|
| UNII | |
| |
| |
| Properties | |
| C14H20N2O | |
| Molar mass | 232.327 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
4-Hydroxy-N-methyl-N-propyltryptamine, commonly known as4-HO-MPT ormeprocin, is apsychedelic drug in thetryptamine class ofchemical compounds and is a higherhomologue of the naturally occurring substituted tryptaminepsilocin as well as being the 4-hydroxylanalog ofMPT.
4-HO-MPT was first synthesized andbioassayed bybiochemistAlexander Shulgin and written about in his 1994 bookTiHKAL.[1]
For psychedelic effects, the dosage and duration are listed as "unknown" in TiHKAL.[1]
Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-HO-MPT. In a single trial of 8 mg orally of 4-HO-MPT HCl from TiHKAL, it is described as producing visual distortion,vertigo, and slightinsomnia.[1]
4-HO-MPT is not scheduled by theUnited Nations'Convention on Psychotropic Substances.[2]
4-HO-MPT is notscheduled at thefederal level in theUnited States,[3] but it is possible that 4-HO-MPT could legally be considered ananalog ofpsilocin, in which case, sales orpossession with intent for human consumption could potentially be prosecuted under theFederal Analogue Act.[4]
